RISPERDAL

Janssen Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: May 28, 2026
Approval ID: 7e117c7e-02fc-4343-92a1-230061dfc5e0
Products: 11 registered
Version: 45

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RISPERDAL safely and effectively. See full prescribing information for RISPERDAL. RISPERDAL(risperidone) tablets, for oral use RISPERDAL(risperidone) oral solution RISPERDALM-TAB (risperidone) orally disintegrating tablets Initial U.S. Approval: 1993

Quick Stats

Total Products11

Labelers2

Label Sections53

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.